Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,089,611 | 5,089,611 | -1,000,000 | $316.29M | $389.30M | 81.29% | +$73.01M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,316,806 | 1,316,806 | 0 | $20.27M | $27.67M | 5.78% | +$7.40M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $10.91M | $23.09M | 4.82% | +$12.18M |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $8.98M | $9.57M | 2.00% | +$591.7K |
| COMPASS Pathways plcADS(CMPS) | 1,198,418 | 1,198,418 | 0 | $6.87M | $8.27M | 1.73% | +$1.40M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 564,625 | 564,625 | 0 | $6.54M | $7.07M | 1.48% | +$530.7K |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $1.60M | $3.43M | 0.72% | +$1.83M |
| Scholar Rock Holding Corporation(SRRK) | 77,031 | 77,031 | 0 | $2.87M | $3.39M | 0.71% | +$524.6K |
| Biomea Fusion, Inc.(BMEA) | 2,048,757 | 2,048,757 | 0 | $4.14M | $2.54M | 0.53% | -$1.60M |
| UroGen Pharma Ltd.(URGN) | 0 | 108,000 | +108,000 | $0 | $2.53M | 0.53% | +$2.53M |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $825.5K | $1.31M | 0.27% | +$482.2K |
| Marker Therapeutics, Inc.(MRKR) | 325,370 | 325,370 | 0 | $290.4K | $484.8K | 0.10% | +$194.4K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 88,607 | 88,607 | 0 | $243.7K | $257.0K | 0.05% | +$13.3K |
| Nuvation Bio Inc.CL A(NUVB) | 2,960,659 | 0 | -2,960,659 | $10.95M | $0 | — | -$10.95M |
| Verona Pharma plc (VRNA)ADS | 615,352 | 0 | -615,352 | $65.66M | $0 | — | -$65.66M |